The Power of In Vitro Assays in Immuno-Oncology
In early drug discovery, comprehensive characterization of compounds can provide insights that improve efficacy downstream. These early-stage platforms are a crucial bridge that support a candidate’s transition from the bench to clinic. This translational research generates information on compounds from each stage of the drug-discovery process to inform and progress therapies rapidly from in-vitro assays to in-vivo studies and, ultimately, successfully to patients.
Martin O’Rourke discusses the power of in vitro assays in immuno-oncology with Pharmaceutical Technology.